Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

Valeant Pharmaceuticals (VRX.TO)

BUY
Strong company/product line. Long term.
BUY
At an attractive price. Good distribution/pipeline.
BUY
Likes pharmaceuticals. A good buy for long term.
BUY
Better diversified than a lot of bio techs. Great growth profile.
HOLD
Successful company. Trading at 35 X earnings. Not cheap but expects some growth.
TOP PICK
A lot of patents coming off next year. Moving from just a generic company into marketing and a pipeline.
BUY
In the short term will probably stay at this level, but would own for long term
TOP PICK
A secure stock.
DON'T BUY
A good company, but will be volatile. Prefers MDS or Patheon
BUY
Good company. When rates go down, valuations go up
BUY
#1 pick in large, Cdn biotechs. Undervalued compared to US. Good varied product lines
BUY
Made a good purchase of Cardizan heart drug. One of the best biotechs
DON'T BUY
Wait to see how their acquisitions work out
BUY
A major player Has done well. Attractive
WATCH
Good company. Valuations need retuning
Showing 691 to 705 of 714 entries